Cargando…

Relationship Between Symptomatic and Functional Improvement and Remission in a Treatment Response to Stimulant Trial

Objective: To evaluate the relationship between symptom and functional improvement and remission in children and adolescents with attention-deficit/hyperactivity disorder (ADHD) enrolled in an 11-week open-label dose-optimization phase of an methylphenidate extended release (MPH-MLR) pivotal study....

Descripción completa

Detalles Bibliográficos
Autores principales:	Weiss, Margaret, Childress, Ann, Mattingly, Greg, Nordbrock, Earl, Kupper, Robert J., Adjei, Akwete L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201781/ https://www.ncbi.nlm.nih.gov/pubmed/30036076 http://dx.doi.org/10.1089/cap.2017.0166

Ejemplares similares

Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release
por: Weiss, Margaret, et al.
Publicado: (2019)

Effect of Aptensio XR (Methylphenidate HCl Extended-Release) Capsules on Sleep in Children with Attention-Deficit/Hyperactivity Disorder
por: Owens, Judith, et al.
Publicado: (2016)

Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study
por: Wigal, Sharon B., et al.
Publicado: (2015)

Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder
por: Childress, Ann C., et al.
Publicado: (2020)

Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
por: Mattingly, Greg W, et al.
Publicado: (2013)

Population pharmacokinetics of methylphenidate hydrochloride extended-release multiple-layer beads in pediatric subjects with attention deficit hyperactivity disorder
por: Teuscher, Nathan S, et al.
Publicado: (2015)

Symptomatic Remission and Counterfactual Reasoning in Schizophrenia
por: Albacete, Auria, et al.
Publicado: (2017)

Spontaneous remission of fully symptomatic visceral leishmaniasis
por: Mouri, Oussama, et al.
Publicado: (2015)

Serdexmethylphenidate/dexmethylphenidate effects on sleep in children with attention-deficit/hyperactivity disorder
por: Mattingly, Greg W., et al.
Publicado: (2023)

A Pharmacokinetic Study of Methylphenidate Hydrochloride Multilayer Extended-Release Capsules (Aptensio XR(®)) in Preschool-Aged Children with Attention-Deficit/Hyperactivity Disorder
por: Adjei, Akwete L., et al.
Publicado: (2020)

Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients
por: Jha, Manish K., et al.
Publicado: (2016)

Symptomatic remission affects employment outcomes in schizophrenia patients
por: Wang, San-Ping, et al.
Publicado: (2020)

Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome
por: Valencia, Marcelo, et al.
Publicado: (2015)

Broader conceptualization of remission assessed by the remission from depression questionnaire and its association with symptomatic remission: a prospective, multicenter, observational study
por: Montoya, Alonso, et al.
Publicado: (2016)

Familial Mediterranean Fever With Complete Symptomatic Remission During Pregnancy
por: Kim, Kwang Taek, et al.
Publicado: (2015)

Correlates of symptomatic remission among individuals with post-COVID-19 condition
por: Perlis, Roy H., et al.
Publicado: (2023)

Symptomatic Remission Along the Clinical Psychosis Spectrum: A Historical and Conceptual Review
por: BİNBAY, Tolga, et al.
Publicado: (2021)

Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophrenia
por: Kim, Honey, et al.
Publicado: (2023)

Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension
por: Weiss, Margaret D., et al.
Publicado: (2020)

Slightly Symptomatic Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Remission in Four Months
por: Tetsuka, Syuichi, et al.
Publicado: (2019)

A randomised controlled trial of neuromuscular stimulation in non-operative venous disease improves clinical and symptomatic status
por: Ravikumar, Raveena, et al.
Publicado: (2020)

Symptomatic and Functional Remission in Young Adults with a Psychotic Disorder in a Rehabilitation Focused Team
por: Kwakernaak, Sascha, et al.
Publicado: (2019)

Symptomatic, Drug-Resistant Narcolepsy Remission After Fenestration of an Arachnoid Cyst – A Case Report
por: Künstler, Erika C S, et al.
Publicado: (2023)

Symptomatic relief precedes improvement of myocardial blood flow in patients under spinal cord stimulation
por: Diedrichs, Holger, et al.
Publicado: (2005)

Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin)
por: Kelly, Deanna L, et al.
Publicado: (2013)

Rate of and time to symptomatic remission in first-episode psychosis in Northern Malawi: A STROBE-compliant article
por: Kaminga, Atipatsa Chiwanda, et al.
Publicado: (2018)

Time courses of improvement and symptom remission in children treated with atomoxetine for attention-deficit/hyperactivity disorder: analysis of Canadian open-label studies
por: Dickson, Ruth A, et al.
Publicado: (2011)

Time to remission analysis for major depressive disorder after repetitive transcranial magnetic stimulation (rTMS)
por: Manzardo, Ann M., et al.
Publicado: (2019)

Ethical issues in HIV remission trials
por: Eyal, Nir, et al.
Publicado: (2018)

Genetic Markers for Later Remission in Response to Early Improvement of Antidepressants
por: Kang, Hee-Ju, et al.
Publicado: (2020)

S48. INSIGHT VS COGNITION AND SYMPTOMATIC REMISSION AMONG PATIENTS WITH SCHIZOPHRENIA- THE INFLUENCE OF TRAIT VS STATE PHENOMENON?
por: Helldin, Lars, et al.
Publicado: (2020)

The Association of Social Support and Symptomatic Remission among Community-Dwelling Schizophrenia Patients: A Cross-Sectional Study
por: Fan, Chi-Hsuan, et al.
Publicado: (2021)

Severity of Depression Predicts Remission Rates Using Transcranial Magnetic Stimulation
por: Grammer, Geoffrey G., et al.
Publicado: (2015)

Metabolic status in children with Cushing’s disease and its relationship with remission
por: Moszczyńska, Elżbieta, et al.
Publicado: (2023)

Curcumin as adjuvant therapy to improve remission in myeloma patients: A pilot randomized clinical trial
por: Santosa, Damai, et al.
Publicado: (2022)

Exploiting antitumor immunity to overcome relapse and improve remission duration
por: Chen, Lei L., et al.
Publicado: (2011)

A Review Exploring the Relationship Between Nursing Home Staffing and Antipsychotic Medication Use
por: Mattingly, T. Joseph
Publicado: (2015)

Time to achieve remission determines time to be in remission
por: Schipper, Lydia G, et al.
Publicado: (2010)

Delayed endoscopic necrosectomy improves hospital length of stay and reduces endoscopic interventions in patients with symptomatic walled‐off necrosis
por: Pawa, Rishi, et al.
Publicado: (2022)

Durability of symptomatic responses obtained with adjunctive vagus nerve stimulation in treatment-resistant depression
por: Kumar, Arun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5elkc22lbg0p3k388e67b7vu80